Navigation Links
University of Minnesota study refutes belief that black men have more aggressive prostate cancer
Date:9/17/2007

130 surgery patients. From these he was able to match 25 black and 25 white patients according to age, Gleason grade (a pathologists measure of how advanced a prostate tumor is), clinical stage of the tumors and PSA levels before prostatectomy.

To determine how aggressive the tumors were, Sinha measured the levels of an enzyme that is essential for destroying membranes that keep cells in place. Called cathepsin B, the enzyme, if unchecked, carves out an escape route by which cancer cells can spread. He also measured the levels of a substance, known as stefin A, that inhibits cathepsin B. The ratio of the two substances in slices of prostate tumors gives a measure of how invasive, or aggressive, the tumors are. The most aggressive ones are characterized by a high ratio of cathepsin B to stefin A.

Results showed that the ratios were not significantly different in tumors of black and white men, all of whom had Gleason score 6 or 7 tumors, indicating moderate risk. The average ratios were 1.78 in black men and 1.59 in white men for Gleason score 6 tumors, and 1.49 in black men and 1.35 in white men of Gleason score 7 tumors. All these ratios were higher than the average ratio in control tissue taken from men with benign prostatic hyperplasia, a common, noncancerous enlargement of the gland.

Sinha said that previous studies had found differences between black men compared to white men and men of other races in terms of prostate cancer incidence, death rate, tumor volume, age, Gleason score and PSA levels. But other factors, such as level of medical care, economic status, access to medical care and nutrition undoubtedly contributed to those differences.

Our selection of patients, who received equal medical care at the Minneapolis Veterans Affairs Medical Center, minimized differences in prostate cancer of African-American and Caucasian patients, he said. Furthermore, previous studies did not include [enzymes like cathepsin B] as a fac
'/>"/>

Contact: Patty Mattern
matte016@umn.edu
612-624-2801
University of Minnesota
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. University of Manchester makes made-to-measure skin and bones a reality using inkjet printers
2. New protein discovered by Hebrew University researchers
3. Next Generation Body Scanner Launched By The University Of Manchester
4. Roundup®highly lethal to amphibians, finds University of Pittsburgh researcher
5. Green catalyst destroys pesticides and munitions toxins, finds Carnegie Mellon University
6. University of Nevada, Reno research team discovers hormone that causes malaria mosquito to urinate
7. Carnegie Mellon University research reveals how cells process large genes
8. University of Delaware researchers develop cancer nanobomb
9. University of Arizona plant scientists to unravel maize genome
10. Team led by Carnegie Mellon University scientist finds first evidence of a living memory trace
11. University of Utah to help build bionic arm

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ON ROUGE Antarctica has long held secrets of the ...l recently, there has been very little information... miles of ice for millions of years. Now, a team o...U have been funded to the tune of $10 million dol...o get to the bottom of things literally. These sc...
(Date:11/23/2009)...ngton, D.C. The community-associated strain of th...a resistant to most common antibioticsposes a far ... making its way into hospitals, according to a stu...iseases . , The new threat is easily picked up ...es and has increased the overall burden of MRSA wi...
(Date:11/23/2009)...ngton, CT Current research suggests that a common... The related report by Nichols et al, "Unique Lip...Class of TLR2 Ligands Capable of Enhancing Autoimm... American Journal of Pathology . , Multiple scle...cks the brain and spinal cord, affects nearly 1 in...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Cambrex Continuous Flow Microwave Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award 5599 1Cambrex Continuous Flow Microwave Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award 5599 2Babies Injured in Car Seats Used Outside of Cars 59817 1Babies Injured in Car Seats Used Outside of Cars 59817 2Babies Injured in Car Seats Used Outside of Cars 59817 3School Meals Need to Get Healthier 3A Report 59815 1School Meals Need to Get Healthier 3A Report 59815 2School Meals Need to Get Healthier 3A Report 59815 3School Meals Need to Get Healthier 3A Report 59815 4
...nced the winners of its student travel award to at...and the International Biophysics Congress in Long ...nts of this competitive award are selected based o...ho will present a paper at the conference. Each a...zed at a reception on Saturday, February 2, 2008. ...
...diopathic pulmonary fibrosis is a disease with unk...cted, it is already in an advanced stage. Patients...ulmonary gas exchange, and have a very reduced qua...tment, they rarely survive 5 years after being dia...ut of 100,000 men and 7 out of 100,000 women, norm...
...unds could make sutures a relic of medical history...laced on a surgical wound and exposed to an infrar... it and the tissue, thus perfectly sealing the wou... is extracted from crab shells and has Food and Dr...t results indicate that it has strongest potential...
Other Biology News:Biophysical Society announces winners of 2008 Student Travel Awards 2Biophysical Society announces winners of 2008 Student Travel Awards 3Biophysical Society announces winners of 2008 Student Travel Awards 4Biophysical Society announces winners of 2008 Student Travel Awards 5Translational research patented first experimental treatment against idiopathic pulmonary fibrosis 2Surgery without stitches 2
(Date:11/23/2009)... communication, computation and more powerful ways...se quantum states as carriers of information is an...ave shown, mathematically, how to gently tease out...eping the information intact. Their work is report...s and highlighted with a Viewpoint in Physics (...
(Date:11/23/2009)...wswire-FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: ...er27,2009astheex-dividenddateforits$200millionspec...ationtransactioncompletedonNovember2,2009.Thedivid...ecordontherecorddate,December1,2009.NASDAQhassetth...hareofcommonstockforpurposesoftheex-dividenddateon...
(Date:11/23/2009)...-FirstCall/--NeogenCorporation(Nasdaq: NEOG )annou...ogen,sBoardofDirectorsatthecompany,srecentannualme...rsofexperienceinthefood,agriculture,andtradeindust...lturaleconomicsatVirginiaTechUniversity.FromJanuar...ulturenegotiatorwiththerankofambassador. ,, "Si...
(Date:11/23/2009)...uneDesignC or p.(IDC)announcedtodaythatDr.BruceL.A...sasuccessfultrackrec or dinbiotechnologyexecutivem...ymoGenetics,inSeattle,WAandChiefScientificOfficera...ttp://www.newscom.com/cgi-bin/prnh/20091123/SF1522...iveOfficercommented,"IamdelightedtowelcomeDr.Bruce...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2
...ocus on Late-Stage and Marketed ...nd OXFORD, England, May 1 ,EUSA Pharma Inc (,EUSA,...y,focused on oncology, pain control and critical c...clonal antibody research business to the French,co...rently, EUSA has,divested its recombinant L-aspara...
...sdaq:,VICL) today announced that the company will ...ch 31, 2008, before the opening of trading on,Thur...cast to discuss the,financial results and provide ... May 8. The call is open on a listen-only basis to...details on independent and partnered,development p...
...:,FVRL), a biopharmaceutical company developing pa...atment of cancer, announced today that it will,hos...Eastern Time on,Thursday, May 8, 2008 to discuss t... A press release will be issued after the U.S. sto...wscom.com/cgi-bin/prnh/20080404/LAF521LOGO ), A l...
Other Biology Technology:EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product 2EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product 3Vical Announces News Release and Conference Call Schedule for First Quarter 2008 Financial Results 2Favrille to Host Conference Call and Live Webcast to Discuss First Quarter 2008 Financial Results on May 8, 2008 2
Rat Anti-Mouse Endoglin Monoclonal Antibody, Fluorescein Conjugated, Clone 209701 from R&D Systems
Goat Anti-Rat CNTF R alpha Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Human MFRP Monoclonal Antibody, Unconjugated, Clone 291218 from R&D Systems
Goat Anti-Human RELT / TNFRSF19L Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: